Inventor
Maria Rosaria Di Fluri
Inventor
Burnaby, CA
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds36%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
A61KPreparations for medical, dental or toiletry purposes16%
Y02ATechnologies for adaptation to climate change16%
PatentTitleYear
8,778,967'Chemokine receptor binding heterocyclic compounds with enhanced efficacy'20147,807,694'Chemokine receptor binding heterocyclic compounds'20107,491,735'Chemokine receptor binding compounds'20097,396,840'Chemokine receptor binding heterocyclic compounds'20087,354,932'Chemokine receptor binding heterocyclic compounds with enhanced efficacy'20087,354,934'Chemokine receptor binding heterocyclic compounds with enhanced efficacy'20087,312,234'Chemokine receptor binding heterocyclic compounds'20077,091,217'Chemokine receptor binding heterocyclic compounds'20067,084,155'Chemokine receptor binding heterocyclic compounds'2006Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2006–2008Patents assigned to ANORMED INC (3)· patent assignee history
2006–2007Patents assigned to ANORMED (2)· patent assignee history
2006–2014Based in Burnaby, CA· patent location history
2008–2014Patents assigned to GENZYME CORP (4)· patent assignee history
2014Patents assigned to ATSMA BEM (1)· patent assignee history
2014Patents assigned to BOGUCKI DAVID (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GENZYME CORP | 4 | 2008–2014 |
| ANORMED INC | 3 | 2006–2008 |
| ANORMED | 2 | 2006–2007 |
| ATSMA BEM | 1 | 2014 |
| BOGUCKI DAVID | 1 | 2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Burnaby, CA | 9 | 2006–2014 |